Trailing Twelve Months Revenue Growth: Pacific Biosciences (PACB)

Pacific Biosciences is advancing personalized medicine by developing ultra-precise tools for reading long genome sequences. The 12-month revenue trajectory displayed on GURU.Markets confirms the pricing power of Revio systems. However, cash deficits and operating losses are forcing the company to raise capital, and the value of 4.50 reflects this current status of sales dynamics.
PacBio Corp (PACB) - metric breakdowns and financial figures

This indicator captures the daily change in rolling year revenue, stripping the fundamental trend of seasonal fluctuations and short-term market noise. Analysis of this rolling 12-month YoY revenue growth chart allows for an assessment of the Revio system's scaling pace and the share of recurring reagent sales revenue, which is critical for monitoring the capital burn rate of Pacific Biosciences (PACB).